Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Julia M. Berger"'
Autor:
Julia M. Berger, Felix Lötsch, Anna S. Berghoff, Wolfgang W. Lamm, Matthias Preusser, Georg Jeryczynski
Publikováno v:
Medical Mycology Case Reports, Vol 45, Iss , Pp 100660- (2024)
Here, we present the case of a patient with a metastatic neuroendocrine tumor with cytologically negative ascites treated for spontaneous bacterial peritonitis (SBP). Ascitic cultures remained negative for bacterial growth but were positive for Candi
Externí odkaz:
https://doaj.org/article/f99ee9dc05b6476586783caa3a831231
Autor:
Clara Brandstetter, Maria C. Haller, Julia M. Berger, Heidrun Kerschner, Petra Apfalter, Daniel Cejka
Publikováno v:
Wiener klinische Wochenschrift. 134(23-24)
Growing evidence shows diminished response to mRNA-based SARS-CoV‑2 vaccination in kidney transplant recipients. We aimed to investigate the seroconversion rate after a 3rd and 4th dose of mRNA vaccination in kidney transplant recipients without pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1b047ea836cf9e2c6e0013bed0047e4
https://pubmed.ncbi.nlm.nih.gov/36326920
https://pubmed.ncbi.nlm.nih.gov/36326920
Autor:
Maximilian J. Mair, Manfred Mitterer, Pia Gattinger, Julia M. Berger, Wolfgang Trutschnig, Arne C. Bathke, Margaretha Gansterer, Anna S. Berghoff, Severin Laengle, Lynn Gottmann, Thomas Buratti, Helmuth Haslacher, Wolfgang W. Lamm, Markus Raderer, Selma Tobudic, Thorsten Fuereder, Rudolf Valenta, Dominic Fong, Matthias Preusser
Publikováno v:
Cancer cell. 40(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd200ceabb4a0f19e94c62fc538b324
https://pubmed.ncbi.nlm.nih.gov/35429443
https://pubmed.ncbi.nlm.nih.gov/35429443
Autor:
Julia M. Berger, Manfred Neuberger
Publikováno v:
International Journal of Occupational and Environmental Medicine. 1:1-9
The aim was to record the smoking behaviour of 13- to 16-year-old Austrian pupils and to investigate changes in smoking behaviour following amendments of legislation and gender-specific differences. The survey took place in Vienna, Lower Austria, Bur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8cc4579035cfdaf455704e0e2b50ff2
https://doi.org/10.14302/issn.2690-0904.ijoe-20-3205
https://doi.org/10.14302/issn.2690-0904.ijoe-20-3205
Autor:
Maximilian J. Mair, Julia M. Berger, Manfred Mitterer, Margaretha Gansterer, Arne C. Bathke, Wolfgang Trutschnig, Anna S. Berghoff, Thomas Perkmann, Helmuth Haslacher, Wolfgang W. Lamm, Markus Raderer, Selma Tobudic, Thorsten Fuereder, Thomas Buratti, Dominic Fong, Matthias Preusser
Publikováno v:
European Journal of Cancer
Background Due to potentially immune-escaping virus variants and waning immunity, a third SARS-CoV-2 vaccination dose is increasingly recommended. However, data in patients with cancer are limited. Patients and methods We measured anti-SARS-CoV-2 spi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::541b65984d1abc6e5a61d3bfc6f69270
http://europepmc.org/articles/PMC8818387
http://europepmc.org/articles/PMC8818387
Autor:
Thorsten Fuereder, Matthias Preusser, G. Ortmayr, Dominic Fong, Manfred Mitterer, Helmuth Haslacher, Julia M. Berger, Wolfgang Lamm, Selma Tobudic, Hannah Christina Puhr, Ariane Steindl, Markus Raderer, Thomas Perkmann, Maximilian J. Mair, Robert Strassl, Angelika M. Starzer, Anna S. Berghoff
Publikováno v:
JAMA Oncol
Importance: To our knowledge, little is known about antibody development after SARS-CoV-2 vaccination in immunocompromised individuals, such as patients with cancer. Objective: To determine whether hematooncological patients develop anti-SARS-CoV-2 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b59e1869e4475ec43b39aeb5345ece
https://pubmed.ncbi.nlm.nih.gov/34591965
https://pubmed.ncbi.nlm.nih.gov/34591965
Autor:
Julia M. Berger, Phillipp Wohlfarth, Oliver Königsbrügge, Hanna A. Knaus, Edit Porpaczy, Hannes Kaufmann, Johanna Schreiber, Tatevik Mrva-Ghukasyan, Thomas Winder, Luciano Severgnini, Dominik Wolf, Verena Petzer, Van Anh Nguyen, Georg Weinlich, Leopold Öhler, Anna Wonnerth, Aurelia Miksovsky, Bert Engelhart, Matthias Preusser, Anna S. Berghoff
Publikováno v:
Wiener klinische Wochenschrift. 134(9-10)
Summary Background Cancer patients infected with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) have an increased risk of mortality. Here, we investigated predictive factors for coronavirus disease 2019 (COVID-19) associated mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c1e5a3ef4960c2a585f35075bb25d25
https://pubmed.ncbi.nlm.nih.gov/35171337
https://pubmed.ncbi.nlm.nih.gov/35171337
Autor:
Maximilian J. Mair, Manfred Mitterer, Pia Gattinger, Julia M. Berger, Rudolf Valenta, Dominic Fong, Matthias Preusser
Publikováno v:
JAMA Oncology. 8:1694
This cohort study assesses the capacity of passive immunization and tixagevimab and cilgavimab to inhibit interaction between receptor-binding domains and angiotensin-converting enzyme 2 in patients with hemato-oncologic diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4332a1ec6236e93e9ba9f3d5a4acd4d8
https://doi.org/10.1001/jamaoncol.2022.4226
https://doi.org/10.1001/jamaoncol.2022.4226
Autor:
Matthias Preusser, Wolfgang Lamm, Arne C. Bathke, Julia M. Berger, Markus Raderer, Robert Strassl, Anna S. Berghoff, Wolfgang Trutschnig, Margaretha Gansterer
Publikováno v:
Wiener Klinische Wochenschrift
SummaryBackgroundDuring the second wave of the coronavirus disease 2019 (COVID-19) pandemic Austria suffered one of the highest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rates worldwide. We report performance parameters of a SARS-C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be48e6a3b08db0f0da2633872fa13a1
https://pubmed.ncbi.nlm.nih.gov/34410467
https://pubmed.ncbi.nlm.nih.gov/34410467